Common first-line treatment for cryptococcal meningitis in being compromised by drug resistancehttps://www.news-medical.net/news/20191208/Common-first-line-treatment-for-cryptococcal-meningitis-in-being-compromised-by-drug-resistance.aspx
2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
Current treatment for fungal meningitis is fueling drug resistancehttps://www.newswise.com/articles/current-treatment-for-fungal-meningitis-is-fueling-drug-resistance
2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
Current treatment for fungal meningitis is fueling drug resistance -- ScienceDailyhttps://www.sciencedaily.com/releases/2019/12/191206114607.htm
2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
Current treatment for fungal meningitis is fuelling drug resistance - News - University of Liverpoolhttps://news.liverpool.ac.uk/2019/12/06/current-treatment-for-fungal-meningitis-is-fuelling-drug-resistance/
2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of ResistanceCryptococcus
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistancehttps://mbio.asm.org/content/10/6/e02575-19
2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance

Showing topic

2019-12 Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance
Fluconazole